71 related articles for article (PubMed ID: 1820880)
1. The effect of aging on the pharmacokinetics of nizatidine.
Villani P; Regazzi MB; Pecorini M; Tizzoni M; Savio D
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():205-10. PubMed ID: 1820880
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of rizatriptan in healthy elderly subjects.
Musson DG; Birk KL; Panebianco DL; Gagliano KD; Rogers JD; Goldberg MR
Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence of two oral formulations of nizatidine capsules in healthy male volunteers.
Lockyer M; Al-Dgither S; Al-Gaai E; Yousuf A; Hammami MM
Biopharm Drug Dispos; 2005 Apr; 26(3):117-20. PubMed ID: 15723428
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
Sasaki M; Sudoh T; Fujimura A
Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
[TBL] [Abstract][Full Text] [Related]
6. The influence of age on the pharmacokinetics of nimodipine.
Mück W; Breuel HP; Kuhlmann J
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):293-8. PubMed ID: 8832305
[TBL] [Abstract][Full Text] [Related]
7. Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
Shah J; Teitelbaum P; Molony B; Gabuzda T; Massey I
Br J Clin Pharmacol; 1991 Dec; 32(6):761-4. PubMed ID: 1768571
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients.
Ford S; Ankier SI; Corless D; Bevan CD; Pidgen AW; Robinson JD; Rangedara DC
Xenobiotica; 1987 Aug; 17(8):1001-9. PubMed ID: 2890241
[TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
[TBL] [Abstract][Full Text] [Related]
10. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
Lefebvre RA; Rosseel MT; Bernheim J
Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
Cloyd JC; Marino S; Birnbaum AK
Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oseltamivir in young and very elderly subjects.
Abe M; Smith J; Urae A; Barrett J; Kinoshita H; Rayner CR
Ann Pharmacother; 2006 Oct; 40(10):1724-30. PubMed ID: 16940405
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
Vaughan D; Speed J; Medve R; Andrews JS
Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
[TBL] [Abstract][Full Text] [Related]
15. Glipizide pharmacokinetics in young and elderly volunteers.
Kobayashi KA; Bauer LA; Horn JR; Opheim K; Wood F; Kradjan WA
Clin Pharm; 1988 Mar; 7(3):224-8. PubMed ID: 3356119
[TBL] [Abstract][Full Text] [Related]
16. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
[TBL] [Abstract][Full Text] [Related]
17. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
18. Effects of age on the pharmacokinetics of mexiletine.
el Allaf D; Carlier J; Dressé A
Int J Clin Pharmacol Res; 1986; 6(4):303-7. PubMed ID: 3759283
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man.
Boneu B; Necciari J; Cariou R; Sié P; Gabaig AM; Kieffer G; Dickinson J; Lamond G; Moelker H; Mant T
Thromb Haemost; 1995 Dec; 74(6):1468-73. PubMed ID: 8772222
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of denbufylline in healthy elderly subjects.
Reim HG; Kurowski H; Bosch K; Brett MA; Ellrich E; Hötzel L; Holz B; Hust R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():274-6. PubMed ID: 1820891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
